NEW YORK (GenomeWeb News) – South Africa's Centre for Proteomic and Genomic Research and researchers from the University of British Columbia are partnering to identify biomarkers that may predict how patients react to vaccinations for seasonal influenza.
CPGR will use its expertise in developing multiplex protein array-based profiling assays and computational solutions for "enhanced" bioinformatics data analysis, CPGR said in a statement. The goal of the project is to create a "biomarker signature assay suitable for companion diagnostic purposes," it added.
Tobias Kollman, assistant professor in the division of infectious and immunological diseases in the department of pediatrics at UBC will lead the university's work on the project. UBC is providing serum samples from a vaccine trial it has been conducting.
Terms of the deal were not disclosed.